2007
DOI: 10.1002/jmv.21088
|View full text |Cite
|
Sign up to set email alerts
|

Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy

Abstract: Hemodialysis patients are at increased risk of hepatitis C virus (HCV) infection. The aim of this study was to investigate a HCV outbreak in a hemodialysis unit using epidemiological and molecular methods. Between April 2003 and October 2003, anti-HCV seronconversion was detected in four patients attending the unit. These cases were added to 10 patients already anti-HCV positive upon admission in the unit. All 14 anti-HCV patients were tested for HCV RNA and HCV genotype. NS5B and HVR1/ E2 genomic regions were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 20 publications
0
20
0
Order By: Relevance
“…35,7–10 The transmission of HCV among patients who were in proximity during the same shift or shared a station between consecutive shifts has also been reported. 1113 …”
Section: Discussionmentioning
confidence: 99%
“…35,7–10 The transmission of HCV among patients who were in proximity during the same shift or shared a station between consecutive shifts has also been reported. 1113 …”
Section: Discussionmentioning
confidence: 99%
“…9 Molecular analysis has emerged as an important tool in establishing transmission events, and has been used to provide evidence of transmission of infection in cases of clinically acquired HCV. [10][11][12][13][14] …”
Section: Introductionmentioning
confidence: 98%
“…Overall HAV accounts for 25% of clinically evident acute hepatitis worldwide, HBV has infected over 2 billion people worldwide with a carrier of 350 million [1][2][3] . HEV accounts for about 50% of cases of sporadic acute hepatitis in India and epidemics have also been reported in Indian subcontinent, sub-Saharan Africa and Mexico [4][5][6] . The global prevalence varies from high >8% in Africa, Asia, Western Pacific region, intermediate 2-7% in South Eastern Europe and low <2.5 in Western Europe, North America and Australia.…”
Section: Introductionmentioning
confidence: 99%
“…The global prevalence varies from high >8% in Africa, Asia, Western Pacific region, intermediate 2-7% in South Eastern Europe and low <2.5 in Western Europe, North America and Australia. Prevalence of HCV is 1.8% in general population in USA, increasing up to 50% in unexplained cirrhosis and hepatocellular carcinoma (HCC) and is the most common cause of chronic liver disease [4][5][6] .…”
Section: Introductionmentioning
confidence: 99%